CoreTissue BioEngineering Inc.

Developing Artificial Ligament for

Knee Anterior Cruciate Ligament Reconstruction


▶ March 18, 2021    CTBE obtained the manufacturing and marketing authorization of the highly controlled  medical devices.


▶Dec. 25, 2020    AMED adopted CTBE to the Grant, "the 5th CiCLE: Cyclic Innovation for Clinical Empowerment 2020"

                                  More Details

▶ Aug. 7, 2020      CoreTissue BioEngineering and Teijin Limited agree on alliance to mass produce artificial ligament

                                  More Details 


▶ July 7, 2020      The annual report of the AMED grant program was published - Japanese only


▶June 18, 2020      The CEO went onto the online platform of the Joint Pitch - Deep Tech for Good: Medical Innovations

                                  sponsored by SGInnovate (Singapore)  and Japan Science and Technology Agency (JST)   More Details

▶ Feb. 12, 2020.     The 2020 renewal of the AMED grant program was approved - Japanese only  

▶ Nov. 26, 2019      The CEO went onto the platform of the 34th NEDO Pitch "Academic Venture x Health-tech" - Japanese only


▶ Nov. 18, 2019    Received grant from the Ogasawara Foundation for the Promotion of Science & Engineering.

▶ Oct. 16, 2019    Funded as the first investment by Waseda University Official Fund - Japanese only

©2019 by CoreTissue BioEngineering Inc. Proudly created with